Misplaced Pages

Draft:Bias Capital

Article snapshot taken from Wikipedia with creative commons attribution-sharealike license. Give it a read and then ask your questions in the chat. We can research this topic together.
This is a draft article. It is a work in progress open to editing by anyone. Please ensure core content policies are met before publishing it as a live Misplaced Pages article.

Find sources: Google (books · news · scholar · free images · WP refs) · FENS · JSTOR · TWL
Easy tools: Citation bot (help) | Advanced: Fix bare URLs · Article logs · Draft logs.

Last edited by JJMC89 bot (talk | contribs) 3 seconds ago. (Update) Finished drafting? Submit for review or Publish now
page is in the middle of an expansion or major revampingThis article or section is in a state of significant expansion or restructuring. You are welcome to assist in its construction by editing it as well. This template was placed by Vortexjourney754 (talk · contribs). If this article or section has not been edited in several days, please remove this template.
If you are the editor who added this template and you are actively editing, please be sure to replace this template with {{in use}} during the active editing session. Click on the link for template parameters to use. This page was last edited by JJMC89 bot (talk | contribs) 3 seconds ago. (Update timer)
This article needs additional citations for verification. Please help improve this article by adding citations to reliable sources. Unsourced material may be challenged and removed.
Find sources: "Bias Capital" – news · newspapers · books · scholar · JSTOR (December 2024) (Learn how and when to remove this message)
Bias Capital
Company typePrivate
IndustryVenture capital
FoundedFebruary 2021; 3 years ago (2021-02)
FounderMaximillian Naza
HeadquartersSan Francisco, California, U.S.
ProductsInvestments
Websitehttps://bias.capital/

Bias Capital, LLC (commonly known as Bias Capital) is an American venture capital firm that invests in both early-stage start-ups and established growth companies. In addition to its primary investments, the firm operates an angel syndicate, offering accredited investors and qualified purchasers the opportunity to access and participate in select investment opportunities.

Founded with the aim of addressing biases in the venture capital industry, Bias Capital is committed to building a portfolio that reflects the diversity of society. The firm seeks to foster inclusive growth by supporting startups that contribute to a more equitable and dynamic business landscape.

Bias Capital operates as the venture capital arm of PasciVite.

Notable Investments

In July 2023, Bias Capital led a $25 million Series A funding round for Parker Health, a biotech company focused on revolutionizing electronic health records and healthcare management.

Other notable investments include Grabango, Wayflyer, Fintor, Valtivis, Flower CO. and FLYR.

References

  1. "Bias Capital". 2021-10-06. Archived from the original on 2021-10-06. Retrieved 2024-12-16.{{cite web}}: CS1 maint: bot: original URL status unknown (link)
  2. "Parker Health Secures $25 Million in Series A Funding to Transform American Healthcare". Archived from the original on 2024-10-05. Retrieved 2024-12-13.
  3. "Bias Capital Investment Portfolio | PitchBook". pitchbook.com. Retrieved 2024-12-16.

Categories: